|Bid||37.97 x 1000|
|Ask||38.15 x 900|
|Day's Range||37.69 - 38.59|
|52 Week Range||31.31 - 47.22|
|Beta (3Y Monthly)||0.22|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 4, 2019 - Nov 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||43.58|
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
NEW YORK, NY / ACCESSWIRE / August 20, 2019, 2018 / Premier, Inc. (North Carolina) (NASDAQ: PINC ) will be discussing their earnings results in their 2019 Fourth Quarter Earnings to be held on August 20, ...
Premier Inc. (PINC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In a new analysis of primary care clinics, Premier Inc. identified wide variation in staffing model composition, performance and costs. Premier® also found that skill mix is not necessarily a predictor of provider productivity. The analysis and opportunities for improvement were published in Premier’s latest Ready, Risk, Reward white paper titled “Optimizing Primary Care Model Design to Improve Performance.” Using its robust database of detailed physician practice information, which includes more than 30,000 clinicians, Premier benchmarked 2018 data from 257 family medicine and primary care practices.
Texas Health Resources and Premier Inc. (PINC) have formed a regional supply chain organization to further scale advancements in total cost management for healthcare providers across North Texas. Texas Health, which provides coordinated care across its 26 hospitals, physician group, trauma centers, outpatient facilities, and home health and preventive services, has worked with healthcare improvement company Premier for more than 20 years to deliver consistent high-quality, affordable care to its communities.
Premier Inc. (PINC) plans to report fiscal 2019 fourth-quarter and full-year financial results the morning of Aug. 20, 2019, followed by a conference call at 8 a.m. ET to discuss the results. During the conference call, Premier’s management will review the company’s performance for the three months and fiscal year ended June 30, 2019 and discuss management’s outlook for fiscal 2020. The conference call will be webcast live and can be accessed through a link provided on the investor relations page of Premier's website at investors.premierinc.com.
Premier Inc. (PINC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sodium bicarbonate injection is most commonly used for urgent treatment of cardiac emergencies, such as cardiac arrest, heart attacks, strokes and other life-threatening emergencies. Limited supplies of the drug today are being imported from Australia under special U.S. Food and Drug Administration (FDA) rules that apply in shortages, but the costs for the imported product are 300 percent higher than the U.S. alternatives. Exela Pharma Sciences is a new producer of sodium bicarbonate, having just received approval for its Abbreviated New Drug Application (ANDA) from the FDA to begin manufacturing.
Premier Inc., a leading healthcare improvement company, has partnered with 26-year, industry expert John Gorman to support its portfolio of value-based payment services for Medicare Advantage providers and participants. Premier members are demanding more support as they build successful Medicare Advantage strategies. Gorman will work directly with Premier’s strategic advisory team to assist providers with Medicare Advantage strategies for success in their markets.
Premier Inc NASDAQ/NGS:PINCView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for PINC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $4.25 billion over the last one-month into ETFs that hold PINC are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Boston Children’s Hospital, one of the largest pediatric medical centers in the U.S., has partnered with Premier Inc. (PINC), a leading healthcare improvement company, to foster optimal management of its supply chain portfolio. Ranked the #1 children's hospital in the nation by U.S. News & World Report, Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School.
Premier Inc. (PINC), a healthcare improvement company, is working with 10 leading hospitals on a perinatal collaborative designed to reach zero preventable maternal and neonatal harm and deaths. Over the next two years, hospitals in Premier’s Perinatal Collaborative will design, test and adopt evidenced-based improvement strategies that can be replicated, standardized and scaled nationally. The collaborative, which launched in June, is part of Premier’s Bundle of Joy™ Campaign to transform the quality, safety and cost of maternal and infant health.
Cysteine hydrochloride has been in shortage in the U.S. since 2015. This FDA-approved New Drug Application (NDA) for cysteine hydrochloride injection is held by Exela Pharma Sciences, LLC, a U.S.-based manufacturer. Current supplies of cysteine hydrochloride injection are imported from Canada under special FDA rules that allow shortage drugs to be sourced abroad if no domestic supplies are available.
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 40% and 25% respectively. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted […]
Premier Inc. , a leading healthcare improvement company, has recognized dozens of hospitals, health systems and suppliers for their outstanding work to improve healthcare quality and costs.
Premier Inc. (PINC), a healthcare improvement company, and Pensiamo Inc., a cognitive supply chain company, have partnered to launch a new pharmaceutical supply chain solution that was co-developed with UPMC, a world-renowned healthcare provider and insurer. CognitiveRx™ is a comprehensive pharmaceutical supply chain solution that predicts, manages and solves for challenges related to drug shortages, inflation, declining reimbursement and other factors impacting the life sciences supply chain. UPMC, which owns Pensiamo, will be the first to implement CognitiveRx to more precisely monitor market demand signals, predict shortage risk and recommend inventory levels that support its ability to insulate patient care from supply disruption.